5-Amino-1MQ vs Oxyntomodulin

Inhibits NNMT enzyme, increasing SAM (S-adenosylmethionine) availability. Alters adipocyte gene expression to reduce fat cell size and may increase brown adipose tissue activity via epigenetic mechanisms.

A small-molecule NNMT (nicotinamide N-methyltransferase) inhibitor that reduces adipocyte differentiation and promotes metabolic shifts in fat cells. Not a true peptide — a synthetic quinolinium compound frequently sold alongside peptide protocols by online vendors.

Dual GLP-1/glucagon receptor agonist. GLP-1 component suppresses appetite; glucagon component increases energy expenditure and fatty acid oxidation. Net effect is reduced caloric intake and elevated metabolic rate.

An endogenous peptide produced in the gut that activates both GLP-1 and glucagon receptors. Dual receptor activation produces appetite suppression plus increased energy expenditure — a combination not achievable with GLP-1 agonists alone.